Oxford BioMedica (OTCMKTS:OXBDF) Shares Shorted: Short Interest Up 56.8% in September

Oxford BioMedica (OTCMKTS:OXBDF) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 184,114 shares, a growth of 56.8% from the August 31st total of 117,438 shares. Based on an average trading volume of 4,206 shares, the short-interest ratio is presently 43.8 days. Approximately 0.2% of the shares of the stock are short sold.

Oxford BioMedica Stock Performance

Shares of OTCMKTS OXBDF remained flat at $6.65 during mid-day trading on Wednesday. 16,707 shares of the stock traded hands, compared to its average volume of 1,634. Oxford BioMedica has a 12 month low of $5.80 and a 12 month high of $12.61. The firm’s fifty day moving average price is $7.03 and its two-hundred day moving average price is $7.71.

Analyst Ratings Changes

Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Oxford BioMedica currently has a consensus rating of “Hold”.

Oxford BioMedica Company Profile

Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.

Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.